NCT06660290View on ClinicalTrials.gov

A Study to Evaluate 0.003% AR-15512 Safety and Drop Attributes

PHASE3CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

January 15, 2025

Primary Completion Date

February 6, 2025

Study Completion Date

February 6, 2025

Conditions
Dry Eye Disease
Interventions
DRUG

0.003% AR-15512 ophthalmic solution

Investigational ophthalmic solution for topical instillation

DRUG

REFRESH® Classic ophthalmic solution

Commercially available ophthalmic solution for topical instillation

Trial Locations (6)

24502

Piedmont Eye Center, Lynchburg

37167

Advancing Vision Research, LLC, Smyrna

38119

Total Eye Care, PA, Memphis

80907

Vision Institute, Colorado Springs

92663

Eye Research Foundation, Newport Beach

01810

Andover Eye Associates, Andover

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY